Effects of tongxinluo on C-reactive protein and clinical prognosis in patients after coronary stenting
- VernacularTitle:通心络对冠心病支架术后C反应蛋白及预后的影响
- Author:
Hongbing XIAO
;
Dadong ZHANG
;
Jun GU
- Publication Type:Journal Article
- Keywords:
Tongxinluo;
Coronary artery disease;
C reactive protein,CRP;
Coronary restenosis
- From:
Journal of Interventional Radiology
2006;0(08):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effects of Tongxinluo on C reactive protein(CRP)and clinical prognosis in patients after coronary stenting. Methods From January 2003 to December 2004, 132 patients in our department diagnosed as coronary artery disease(including acute myocardial infarction, unstable angina pectoris and stable angina pectoris)were divided into two groups: Tongxinluo group and control group. The control group received routine treatment, while Tongxinluo group based on routine treatment was administrated with Tongxinluo capsule in combination for 6 months. Results CRP level was much lower in Tongxinluo group together with apparent decrease of the major adverse cardiac event(MACE)rate in 6 months' follow-up than those of the control group, but showing no difference in coronary arterial restenosis between the two groups at 6 months after coronary stenting. Conclusion Tongxinluo has favorable effects to decrease the CRP level and improve clinical efficiency together with prognosis for patients after coronary stenting.
